Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Emeritus Professor Philip Home

Newcastle AuthorsTitleYearFull text
Emeritus Professor Philip Home
Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison2021
Emeritus Professor Philip Home
Future directions in insulin therapy2021
Emeritus Professor Philip Home
Heart failure management; a perspective from diabetes care2021
Emeritus Professor Philip Home
Tackling obesity during the COVID-19 pandemic2021
Emeritus Professor Philip Home
The evolution of insulin therapy2021
Emeritus Professor Philip Home
How Valid Are the New Hypoglycemia Definitions for Use in Clinical Trials?2020
Emeritus Professor Philip Home
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial2020
Emeritus Professor Philip Home
Impact of a weekly glucagon-like peptide 1 receptor agonist, albiglutide, on glycemic control and on reducing prandial insulin use in type 2 diabetes inadequately controlled on multiple insulin therapy: A randomized trial2020
Emeritus Professor Philip Home
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis2020
Emeritus Professor Philip Home
Is Insulin Therapy Safe?2020
1234567891011121314151617181920...